These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

263 related items for PubMed ID: 31188486

  • 1. Histological subtype remains a prognostic factor for survival in nasopharyngeal carcinoma patients.
    Pan XX, Liu YJ, Yang W, Chen YF, Tang WB, Li CR.
    Laryngoscope; 2020 Mar; 130(3):E83-E88. PubMed ID: 31188486
    [Abstract] [Full Text] [Related]

  • 2. Lymph Node Status and Outcomes for Nasopharyngeal Carcinoma According to Histological Subtypes: A SEER Population-Based Retrospective Analysis.
    Guo R, Wu H, Wang J, Lian CL, He ZY, Zhang WW, Chen YX, Wu SG.
    Adv Ther; 2019 Nov; 36(11):3123-3133. PubMed ID: 31559602
    [Abstract] [Full Text] [Related]

  • 3. Survival comparison of Three histological subtypes of lung squamous cell carcinoma: A population-based propensity score matching analysis.
    An N, Leng X, Wang X, Sun Y, Chen Z.
    Lung Cancer; 2020 Apr; 142():13-19. PubMed ID: 32062199
    [Abstract] [Full Text] [Related]

  • 4. Subtype Specific Nasopharyngeal Carcinoma Incidence and Survival Trends: Differences between Endemic and Non-Endemic Populations.
    Argirion I, Zarins KR, Suwanrungruang K, Pongnikorn D, Chitapanarux I, Sriplung H, Vatanasapt P, Rozek LS.
    Asian Pac J Cancer Prev; 2020 Nov 01; 21(11):3291-3299. PubMed ID: 33247687
    [Abstract] [Full Text] [Related]

  • 5. Impact of marital status at diagnosis on survival and its change over time between 1973 and 2012 in patients with nasopharyngeal carcinoma: a propensity score-matched analysis.
    Xu C, Liu X, Chen YP, Mao YP, Guo R, Zhou GQ, Tang LL, Lin AH, Sun Y, Ma J.
    Cancer Med; 2017 Dec 01; 6(12):3040-3051. PubMed ID: 29034993
    [Abstract] [Full Text] [Related]

  • 6. Role of combined surgical and radiotherapy treatment in nonmetastatic WHO I nasopharyngeal carcinoma patients.
    Wang ZM, Zhu SY, Wang Q, Duan CY, Liu SH, You R, Chen MY, Huang PY.
    Acta Otolaryngol; 2024 Apr 01; 144(4):325-332. PubMed ID: 39033361
    [Abstract] [Full Text] [Related]

  • 7. Survival comparison of different histological subtypes of oropharyngeal squamous cell carcinoma: A propensity-matched score analysis based on SEER database.
    Li T, Wang Y, Xiang X, Chen C.
    Ear Nose Throat J; 2022 Nov 01; ():1455613221136360. PubMed ID: 36317416
    [Abstract] [Full Text] [Related]

  • 8. Pattern and prognosis of distant metastases in nasopharyngeal carcinoma: A large-population retrospective analysis.
    Qu W, Li S, Zhang M, Qiao Q.
    Cancer Med; 2020 Sep 01; 9(17):6147-6158. PubMed ID: 32649056
    [Abstract] [Full Text] [Related]

  • 9. Effect of chemotherapy on survival in patients with stage T3-4N0M0 nasopharyngeal carcinoma.
    Pan XB, Qu S, Li L, Chen L, Liang SX, Zhu XD.
    Clin Otolaryngol; 2021 Jul 01; 46(4):802-808. PubMed ID: 33580628
    [Abstract] [Full Text] [Related]

  • 10. Socioeconomic Status and Survival in Nasopharyngeal Carcinoma: A Population-Based Study.
    Brody-Camp S, McCoul ED, Lefante JJ, Aslam R.
    Laryngoscope; 2021 Dec 01; 131(12):2719-2723. PubMed ID: 34160091
    [Abstract] [Full Text] [Related]

  • 11. The efficacy of chemotherapy in survival of stage II nasopharyngeal carcinoma.
    Pan XB, Li L, Qu S, Chen L, Liang SX, Zhu XD.
    Oral Oncol; 2020 Feb 01; 101():104520. PubMed ID: 31841883
    [Abstract] [Full Text] [Related]

  • 12. Efficacy of chemoradiotherapy in survival of stage Ⅳ nasopharyngeal carcinoma and establishment of a prognostic model.
    Luo HD, Xia FJ, Wu JH, Yi B.
    Oral Oncol; 2022 Aug 01; 131():105927. PubMed ID: 35679694
    [Abstract] [Full Text] [Related]

  • 13. Metastatic Patterns and Prognosis of de novo Metastatic Nasopharyngeal Carcinoma in the United States.
    Xu Y, Huang T, Mao M, Zhai J, Chen J.
    Laryngoscope; 2021 Apr 01; 131(4):E1130-E1138. PubMed ID: 32833262
    [Abstract] [Full Text] [Related]

  • 14. A Comprehensive Analysis of Treatment Management and Survival Outcomes in Nasopharyngeal Carcinoma.
    Goshtasbi K, Lehrich BM, Birkenbeuel JL, Abiri A, Harris JP, Kuan EC.
    Otolaryngol Head Neck Surg; 2021 Jul 01; 165(1):93-103. PubMed ID: 33231508
    [Abstract] [Full Text] [Related]

  • 15. Impact of age on survival of locoregional nasopharyngeal carcinoma: An analysis of the Surveillance, Epidemiology, and End Results program database, 2004-2013.
    Huang SJ, Tang YY, Liu HM, Tan GX, Wang X, Zhang H, Yang F, Yang S.
    Clin Otolaryngol; 2018 Oct 01; 43(5):1209-1218. PubMed ID: 29688619
    [Abstract] [Full Text] [Related]

  • 16. Prognostic models for 1-year survival of NPC after radiotherapy in different ages.
    Zhang QX, Zhuang LP, Lin ZY.
    Eur Arch Otorhinolaryngol; 2021 Dec 01; 278(12):4955-4965. PubMed ID: 33715019
    [Abstract] [Full Text] [Related]

  • 17. Benefits of local tumor excision and pharyngectomy on the survival of nasopharyngeal carcinoma patients: a retrospective observational study based on SEER database.
    Sun J, Huang Z, Hu Z, Sun R.
    J Transl Med; 2017 May 30; 15(1):116. PubMed ID: 28558725
    [Abstract] [Full Text] [Related]

  • 18. Prognostic Value of the Albumin-to-Alkaline Phosphatase Ratio before Chemoradiotherapy in Patients with Nonmetastatic Nasopharyngeal Carcinoma.
    Yang L, Gao J, Zhou Y, Tao Z, He J, Yang J, Wang R, Zhang Y, Huang Y, Zhou L, Sun B.
    Chemotherapy; 2021 May 30; 66(1-2):40-46. PubMed ID: 33601377
    [Abstract] [Full Text] [Related]

  • 19. Maximal lymph nodal diameter on N stage of nasopharyngeal carcinoma.
    Huang ST, Qu S, Li L, Chen KH, Zhu XD, Pan XB.
    Medicine (Baltimore); 2021 Jul 02; 100(26):e26543. PubMed ID: 34190192
    [Abstract] [Full Text] [Related]

  • 20. Survival among subgroups of patients with stage II nasopharyngeal carcinoma.
    Huang ST, Su DK.
    Sci Rep; 2022 Apr 29; 12(1):7007. PubMed ID: 35488053
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.